Press Releases
- NOTICE OF EXTRAORDINARY GENERAL MEETING
- Active Biotech announces a fully secured rights issue of approximately SEK 70 million
- Positive results from Active Biotech’s clinical phase I LION study to be presented at AAO 2025 in October
- INTERIM REPORT Q2 2025
- Active Biotech provides status update of its development programs